Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 15,344 |
|
|||||
| News | - | ||||||
| Day High | 15.135 | Low High |
|||||
| Day Low | 14.82 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Gyre Therapeutics Inc | GYRE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.17 | 1.15% | 14.99 | 11:00:22 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.86 | 14.82 | 15.135 | 14.82 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 358 | 15,344 | US$ 14.94 | US$ 229,309 | - | 5.88 - 30.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:00:22 | 1 | US$ 15.11 | USD |
Gyre Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 37.78M | 2.53M | - | 113.45M | -92.93M | -36.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Gyre Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/26/2024 | 05:00 | GlobeNewswire Inc. | Gyre Therapeutics Reports Full Year 2023 Financial Results.. |
| 3/21/2024 | 06:00 | GlobeNewswire Inc. | Gyre Therapeutics Expands Board of Directors with.. |
| 12/15/2023 | 08:04 | PR Newswire (US) | Totus Medicines Announces Appointment of Nassim Usman,.. |
| 11/13/2023 | 06:00 | GlobeNewswire Inc. | Gyre Therapeutics Presents Poster at the American.. |
| 11/02/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/01/2023 | 16:18 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/01/2023 | 15:58 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GYRE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.44 | 16.48 | 13.50 | 14.37 | 65,646 | -1.45 | -8.82% |
| 1 Month | 16.87 | 17.25 | 13.3241 | 15.60 | 76,116 | -1.88 | -11.14% |
| 3 Months | 11.4428 | 26.37 | 10.41 | 17.39 | 76,304 | 3.55 | 31.00% |
| 6 Months | 7.45 | 30.40 | 7.45 | 18.76 | 97,596 | 7.54 | 101.21% |
| 1 Year | 7.00 | 30.40 | 5.88 | 18.59 | 95,109 | 7.99 | 114.14% |
| 3 Years | 7.00 | 30.40 | 5.88 | 18.59 | 95,109 | 7.99 | 114.14% |
| 5 Years | 7.00 | 30.40 | 5.88 | 18.59 | 95,109 | 7.99 | 114.14% |
Gyre Therapeutics Description
| Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants. |
